Search for: "More v. Johnson"
Results 4941 - 4960
of 5,441
Sorted by Relevance
|
Sort by Date
4 Oct 2018, 9:01 pm
Indeed, in Gratz v. [read post]
12 Feb 2019, 11:35 am
See Lynn v. [read post]
26 Nov 2007, 7:49 am
Gary Johnson, Ph.D. [read post]
2 Apr 2020, 8:10 am
See U.S. v. [read post]
19 May 2024, 9:01 pm
” The Supreme Court held in International Union, UAW v. [read post]
15 Nov 2010, 12:57 am
Co. v. [read post]
27 Feb 2008, 1:17 pm
Heller v. [read post]
12 Jan 2017, 12:04 pm
In Roach v. [read post]
29 Dec 2024, 9:07 pm
Johnson, Duke University Sanford School of Public Policy, David I. [read post]
21 Mar 2011, 10:25 am
Pirri: Barnes v. [read post]
4 Apr 2011, 12:30 am
A week after i4i's filing, the US government joined 21 other amici curiae briefs in support of i4i, including General Electric, Procter & Gamble, and Johnson & Johnson. [read post]
2 May 2016, 2:50 pm
That’s where the imbalance comes: relatively manageable cost of doing business v. creation side is being killed by piracy and dealing w/great burdens from §512 to little effect. [read post]
18 Feb 2010, 10:34 am
We’re talking about fraud on the FDA claims that plaintiffs purport to bring under other federal statutes – chiefly the Lanham Act, RICO, and more recently, the False Claims Act. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
3 Jul 2024, 3:19 pm
In Ohio v. [read post]
16 Nov 2011, 7:09 am
Citizens - http://bit.ly/vkPXsF (Gibbons) Watchdog (SEC) v. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
3 Apr 2018, 1:05 pm
People of the State of California v. [read post]
6 Nov 2008, 3:03 pm
The Court has already rejected the same argument in Scheanette v. [read post]
22 Jun 2017, 5:12 am
When the case was argued on November 30, Kevin Johnson reported that the justices “appeared deeply divided. [read post]
